YourVoice.Now
Back to Dashboard
S-3087Crime and Law Enforcement

Stop Pills That Kill Act

YourVoice.Now Summary

Counterfeit pills that look like real prescription medications but actually contain fentanyl or methamphetamine are killing thousands of Americans each year. This bill expands existing laws against counterfeit drugs to explicitly cover fake pills containing fentanyl, fentanyl analogs, or meth. It also requires the DEA to develop a comprehensive plan within 180 days to investigate and seize counterfeit substances, improve education and prevention efforts targeting youth, and audit public awareness campaigns like "One Pill Can Kill." The Attorney General must report annually to Congress on seizures and prosecutions.

Congressional Summary

Stop Pills That Kill Act This bill increases criminal penalties for offenses relating to the manufacture of fentanyl or counterfeit substances. It also establishes requirements for federal agencies to address the use of counterfeit substances. Specifically, the bill applies an increased criminal penalty for possessing, manufacturing, or distributing certain equipment or materials that are used to illegally manufacture fentanyl, an analogue of fentanyl, or a counterfeit substance (the increased penalty is currently limited to offenses involving methamphetamine). The Drug Enforcement Administration must establish and implement a plan to address counterfeit fentanyl or methamphetamine substances through law enforcement action and education and prevention efforts. In addition, the Department of Justice must annually report on the collection of counterfeit fentanyl or methamphetamine substances by law enforcement and on related prosecutions.

Details

Congress
119th
Chamber
Status
summarized
Action
Action Date
Date Added
2026-04-02
Source
Congress.gov →

Like reading a bill in plain English?

We're building an app that does this for every bill in Congress and lets you tell your reps how you want them to vote. We're a small team getting ready to launch, and we're trying to show investors that real people want this. Be one of them. Help us get it built. Leave your email and we'll tell you the moment the app is ready.

By default, we'll only email you once — when the app launches. Unless you opt in below, you won't receive anything else. We don't share or sell your email.